The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: A kinetic study

被引:69
作者
Skaff, Ojia [1 ]
Pattison, David I. [1 ]
Davies, Michael J. [1 ]
机构
[1] Heart Res Inst, Sydney, NSW 2050, Australia
关键词
D O I
10.1021/bi800786q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasmalogens, which contain a vinyl ether bond, are major phospholipids of the plasma membranes of endothelial and vascular smooth muscle cells and cardiac myocytes. These lipids, in contrast to other phospholipids, have been reported to be targets of HOCl/HOBr generated by myeloperoxidase, with elevated levels of the products of these reactions (alpha-chloro/alpha-bromo aldehydes and unsaturated lysophospholipids) having been detected in human atherosclerotic lesions. The reason(s) for the targeting of this lipid class, over other phospholipids, is poorly understood, and is examined here. It is shown that HOCI and HOBr react with a model vinyl ether (ethylene glycol vinyl ether) 200-300-fold faster (k = 1.6 x 10(3) and 3.5 x 10(6) M(-1) s(-1), respectively) than with aliphatic alkenes (models of phospholipids). True plasmalogens react ca. 20-fold slower than the models. Chloramines and bromamines (from reaction of HOCl/HOBr with primary amines and alpha-amino groups) also react with vinyl ethers, unlike aliphatic alkenes, with k = 10(-3)-10(2) M(-1) s(-1) for chloramines (with the His side chain chloramine being the most reactive, k = 172 M(-1) s(-1)) and k = 10(3)-10(4) M(-1) s(-1) for bromamines. The bromamine rate constants are typically 10(5)-10(6) larger than those of the chloramines. Intermolecular vinyl ether oxidation by phospholipid headgroup bromamines can also occur. These kinetic data indicate that plasmalogens are significantly more susceptible to oxidation than the aliphatic alkenes of phospholipids, thereby rationalizing the detection of products from the former, but not the latter, in human atherosclerotic lesions.
引用
收藏
页码:8237 / 8245
页数:9
相关论文
共 50 条
  • [1] Eosinophil peroxidase-derived reactive brominating species target the vinyl ether bond of plasmalogens generating a novel chemoattractant, α-bromo fatty aldehyde
    Albert, CJ
    Thukkani, AK
    Heuertz, RM
    Slungaard, A
    Hazen, SL
    Ford, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) : 8942 - 8950
  • [2] Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis
    Brautigam, C
    Engelmann, B
    Reiss, D
    Reinhardt, U
    Thiery, J
    Richter, WO
    Brosche, T
    [J]. ATHEROSCLEROSIS, 1996, 119 (01) : 77 - 88
  • [3] Differential reactivities of hypochlorous and hypobromous acids with purified Escherichia coli phospholipid:: formation of haloamines and halohydrins
    Carr, AC
    van den Berg, JJM
    Winterbourn, CC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998, 1392 (2-3): : 254 - 264
  • [4] Peroxidase-mediated bromination of unsaturated fatty acids to form bromohydrins
    Carr, AC
    Winterbourn, CC
    vandenBerg, JJM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 327 (02) : 227 - 233
  • [5] Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice
    Choi, DK
    Pennathur, S
    Perier, C
    Tieu, K
    Teismann, P
    Wu, DC
    Jackson-Lewis, V
    Vila, M
    Vonsattel, JP
    Heinecke, JW
    Przedborski, S
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (28) : 6594 - 6600
  • [6] Mammalian heme peroxidases: From molecular mechanisms to health implications
    Davies, Michael J.
    Hawkins, Clare L.
    Pattison, David I.
    Rees, Martin D.
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2008, 10 (07) : 1199 - 1234
  • [7] Molar absorption coefficients for the reduced Ellman reagent: reassessment
    Eyer, P
    Worek, F
    Kiderlen, D
    Sinko, G
    Stuglin, A
    Simeon-Rudolf, V
    Reiner, E
    [J]. ANALYTICAL BIOCHEMISTRY, 2003, 312 (02) : 224 - 227
  • [8] Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia
    Goodenowe, Dayan B.
    Cook, Lisa L.
    Liu, Jun
    Lu, Yingshen
    Jayasinghe, Dushmanthi A.
    Ahiahonu, Pearson W. K.
    Heath, Doug
    Yamazaki, Yasuyo
    Flax, John
    Krenitsky, Kevin F.
    Sparks, D. L.
    Lerner, Alan
    Friedland, Robert P.
    Kudo, Takashi
    Kamino, Kouzin
    Morihara, Takashi
    Takeda, Masatoshi
    Wood, Paul L.
    [J]. JOURNAL OF LIPID RESEARCH, 2007, 48 (11) : 2485 - 2498
  • [9] Neuronal expression of myeloperoxidase is increased in Alzheimer's disease
    Green, PS
    Mendez, AJ
    Jacob, JS
    Crowley, JR
    Growdon, W
    Hyman, BT
    Heinecke, JW
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 90 (03) : 724 - 733
  • [10] Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786